POPULARITY
This week on the Dirt and Vert Podcast, we're joined by the inspiring Zandy Mangold, an ultra runner who's not afraid to chase those epic challenges.Zandy takes us on his incredible journey, from those early days on the trails to tackling the legendary Spartathlon, one of the toughest ultra marathons in the world. We talk about the highs and lows, the lessons learned, and the transformative power of running.Zandy opens up about the importance of coaching and mentorship, the strength of the running community, and how his passion for the sport has shaped his life.We also dive into Zandy's invaluable advice for new runners, emphasizing the importance of confidence, patience, and recovery. It's a reminder that running is a journey, not a race, and that everyone's path is unique.Zandy's story is one of perseverance, personal growth, and the unwavering belief in the human spirit. It's a must-listen for anyone who's ever chased a dream.Chapters31:58 The Hardest Race: Spartathlon Experience37:58 Crossing the Finish Line: Emotions and Community41:56 Pride in Achievements: Reflecting on Races44:48 Becoming Coach Zandy: A Natural Progression47:54 The Joy of Coaching: Supporting Runners53:21 Advice for New Runners: Building a Strong Foundation01:02:58 The Importance of Recovery in Running01:06:52 Motivation Behind Running01:11:16 Experiences from Badwater Ultra Marathon01:18:39 Setting a Marathon PR at 5001:23:46 Community and Coaching in Running
We love to hear from our listeners. Send us a message. Zandy Forbes, Ph.D. learned about business risk mitigation in the riskiest of business environments. She was a public markets healthcare investor on Wall Street for well more than a decade. Her hedge fund experience followed the Human Frontiers/Howard Hughes postdoctoral fellowship at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center that was preceded by an Oxford Ph.D. in Molecular Genetics. Since 2015, she's been drawing from her immersion in both the business and science disciplines as President & CEO at Meira GTx. On this episode of the Business of Biotech, Dr. Forbes and I go into deep analysis mode as we examine the risks she's taken in her current role, and how she applies her experiences – both good and bad – with handling other people's money to building a biotech company. Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: matt.pillar@lifescienceconnect.comFind Matt Pillar on LinkedIn: https://www.linkedin.com/in/matthewpillar/
On this episode, host Lori Boll speaks with Alexandra “Zandy” Wong who shared her personal journey with hearing loss and her mission to make the digital world more accessible. Zanday's experience inspired her to found the NextGen Accessibility Initiative, which has reached over 200,000 youth across 119 countries. She discussed key aspects of digital accessibility, including proper captioning, alt text for images, and color contrast considerations. Currently pursuing a master's in Applied Digital Health at Oxford as a Rhodes Scholar, Zandy outlined her vision for a fully accessible digital world, emphasizing the need for inherently accessible platforms, cultural shifts in perceiving disability, and ensuring assistive technologies are available to all. Connect Email: alexandrawong2002@gmail.com Website: NextGen Accessibility Initiative LinkedIn
See omnystudio.com/listener for privacy information.
Zandy Forbes, Founder, President, and CEO of MeiraGTx, joins host Rahul Chaturvedi in this compelling episode. Zandy shares her inspiring journey from academia, where she developed a deep interest in molecular biology and genetics, to her significant role in biotech investing, and eventually leading a groundbreaking gene therapy company. She elaborates on Meira's cutting-edge approach to genetic medicines, focusing on the development of innovative therapies for non-inherited diseases. Zandy discusses the unique challenges and opportunities that arise in the biotech sector, shedding light on the strategies Meira employs to navigate this complex landscape. Biography: Alexandria Forbes, Ph.D. is the President and CEO of MeiraGTx (NASDAQ: MGTX). MeiraGTx is a vertically integrated gene therapy company with core capabilities in viral vector design and optimization and gene therapy manufacturing, as well as a potentially transformative gene regulation technology. The company is developing innovative gene therapy products to cost effectively treat a range of serious medical disorders, with clinical programs currently in the eye, salivary gland and CNS. Prior to founding MeiraGTx, Dr. Forbes served as Senior Vice President of Commercial Operations at Kadmon Holdings, Inc., a biopharmaceutical company, from September 2013 to April 2015.Before joining the biotech industry, she spent 10 years as a healthcare investor at Sivik Global Partners (Argus Partners) and Meadowvale Partners. At Sivik, Dr. Forbes was responsible for investments in biotechnology, specialty pharmaceuticals and diagnostics public equities and was portfolio manager of the Sivik Global Life Science Fund, a long-biased public markets fund investing in biotechnology companies globally. During her time as a biotechnology investor, Dr. Forbes covered over 300 companies and gained expertise in biotechnology business strategies and clinical drug development as well as a wide range of disease areas. Particular areas of focus included HIV, HCV, diabetes, obesity, autoimmune disorders, cancer, Alzheimer's disease, kidney disease and liver disease. Before entering the hedge fund industry, Dr. Forbes was an academic scientist studying the regulation of stem cell identity and different aspects of embryogeneis. She was a Human Frontiers/Howard Hughes postdoctoral fellow at the Skirball Institute of Biomolecular Medicine at NYU Langone Medical Center, where her research focused on cytoplasmic determinants and cell signaling pathways involved in the migration, establishment and maintenance of germ line stem cells in Drosophila melanogaster. Prior to this, Dr. Forbes was a research fellow at Duke University and at the Carnegie Institute at Johns Hopkins University where she studied the role of the hedgehog gene and its signaling pathway in the Drosophila embryo and adult. Dr. Forbes received her Ph.D. in Molecular Genetics from Oxford University, UK and attained a double first degree in Natural Sciences from Cambridge University, UK. Dr. Forbes serves on the Board of Directors of MeiraGTx, and as a Trustee and Director of the Selfridges Group Foundation, the European arm of the Weston Brain Institute, a charity supporting research into neurodegenerative diseases with the aim of speeding the time to the development of disease modifying treatments for these currently intractable diseases, particularly Alzheimer's.
Zandy Mangold is an ultramarathon runner, running coach and high-spirited guy who has completed — and in some cases won — some of the world's toughest endurance races. Zandy shares experiences running the Spartathlon (153 miles, Western States (100 miles) and Badwater (135 miles) and the Altacama Crossing (155 miles), the latter of which he won. In his coaching life, Zandy works with people of all ability levels at any stage of their running journey. On the side, Zandy has a business baking plant-based cookies. Even if you aren't an endurance athlete, you're likely to gain something from this episode and be drawn in by Zandy's worldview. Zandy is organizing a 10K race in association with the upcoming Beacon Bonfire festival on Nov 4-5. The Beacon Bonfireball 10K will take place the morning of Nov 4 and is sure to be a great excursion for both competitive and casual runners. Find the registration link at BeaconBonfire.com
In this episode, Brian and Sonia sit down with musical artists Tavior and Zandy Mowry to discuss the importance of living a life of vulnerability and connection. APARTMENT LIFE: If you want to learn more about becoming a coordinator for apartment life and to start the application process go to https://Apartmentlife.org/brianandsonia Learn more about your ad choices. Visit megaphone.fm/adchoices
Colt and Philip are joined today by Zandy Mowry, the guitar player for The New Respects. We feel lucky to call Zandy a close friend of Walrus, and in this episode she was open about the artists who influenced early versions of her band, how her switch from acoustic to electric guitar influenced the direction and style the band has been on for the last several years, and unpacks the meaning of some of their top songs.
Humor is how you get through the tough stuff. Chip MacLaughlin of Rufus Racing shares memories of early KOH, racing with friends, making memories, and Zandy Willems. This is life and how we live it. Thanks, Chip for a beautiful reminder.6:25 – we built a lot of fences, dug a lot of holes9:44 – I got pulled out by four train cars17:25 – oh, by the way, it has to float 21:33 – I sold the buggy, then you called and said I had a spot at Hammers26:06 – the Crawling Chaos guys out of Central Texas were my first race friends37:38 – don't be afraid to ask somebody questions46:17 – we were meant to be together49:08 – almost all males get prostate cancer, the majority die before they know55:36 – we did it with humor, and I think we helped some other people57:13 – the whole point of the team was, let's go make some memories and find friends1:08:08 – my last words to Zandy while I was standing in the spotter stand at Crandon…We want to thank our sponsors Maxxis Tires and 4Low Magazine.www.maxxis.comwww.4lowmagazine.com Be sure to listen on your favorite podcast app.Support the show
We hope this small fraction of time that we got to spend with Zandy can live on forever for his family and friends. Godspeed brother.
On this episode Joe talks to Ultramarathon runner Zandy Mangold. He competes across the globe and has completed over 10 races that were 100+ miles. Highlights of his career include him winning both the 250km Atacama Crossing and the Keys 100. Check out his instagram @run_n_shoot and his coaching website https://www.chaski.run/team-collection/zandy-mangold
Well first of all... what an awesome open segment on this week's show! You will be entertained, that's a promise! We have a big announcement this week from Rocky Mountain Speed and Fab, we hear about Hopper's 'interesting' week, and then we got to hang out with Zandy Willems from Rufus Racing! A lot of folks have heard of Rufus Racing, a two car team that runs in Ultra4's Unlimited 4400 Class. Well this week we got the opportunity to learn a little more about the team, how they started, and what these crazy Texans are planning next!
In this interview, we interview special guest singer Zany Storm.About Zany Storm:Zandy Storm, originally from the Philippines, has been a singer her whole life who auditioned for Philippine Idol during her career. Struggling to get a singing career off the ground, Zandy made her way through all of the traditional routes an artist would take in an attempt to reach success. She eventually started singing background vocals for other famous artists from overseas.Zandy eventually found love, was married and moved to Minnesota where she now resides.
Es gibt etwas Neues von Drake! „Wie bitte?!“, mögt Ihr euch nach kurzem Jubeln fragen. Was hat Drake mit Nintendo zu tun? Meinen wir den Rapper? Oder den Helden aus „Uncharted“? Das wollen wir an dieser Stelle noch nicht verraten, daher empfehlen wir Euch in die Episode 23 Part II reinzuhören. Beginnen werden wir mit einer Runde „The Legend of Zandy“. Im Anschluss daran gibt es ein paar aktuelle Spieleindrücke, um dann weitere Neuigkeiten zu besprechen. Genau da wird es spannend! Aber hört selbst… Eure Tanooki Bros. Intro: SVSX - Tanooki Bros. Theme Outro: Pokemon Gold/Silber – Bicycle Theme
Today's episode features Zandy Wong, a second year undergraduate student at Johns Hopkins University, scientist, disability advocate, and a researcher in the science of hearing loss. Zandy is also the founder of the NextGen Accessibility Initiative where she helps Gen Z educational organizations run by Gen Z fix digital accessibility gaps in their content. Her work through the NextGen Accessibility Initiative has helped over 61,000 students across 119 countries have access to accessible digital content. We discuss how Zandy's experience as someone with hearing loss fuels her advocacy, the importance of policy in achieving greater accessibility for the disabled community, and how initiatives/nonprofits can take steps to become more accessible. Take a listen!NextGen Accessibility: https://www.instagram.com/nextgenaccessibility/ GET CONNECTED W/ THE BRIGHT-EYED:Website: https://thebrighteyedpod.carrd.co/ Instagram: @thebrighteyedpodYouTube: www.youtube.com/channel/UCctFEZ2wEjVd_N2l5WPCpLg?view_as=subscriber LinkedIn: www.linkedin.com/company/thebrighteyed
Lean in and listen to the beyond-her-years insights of our friend Zandy Mowry of the most appealing folk-rock band, The New Respects. With her sheer big-hearted love, Mrs. Mowry challenges each of us to establish personal relationships with individuals, not just an association with sweeping movements, as we all seek understanding and healing in the racial tensions persisting throughout our country, and our world, in this very special third conversation celebrating Black History Month on Bridges. This week's featured song is: "What Makes the World" from the album, Before the Sun Goes Down, by The New Respects. Listen to it here. Learn more about Bridges ... Spiritual Conversations Through Generational Conversations here: BridgesShow.com. And if you like what you are listening to, leave us a 5-star rating and a review, and follow and subscribe to Bridges –– it truly does help us keep chuggin' along as we create new episodes for you! Follow Patsy on Facebook, Instagram and Twitter. Follow Andrew on Facebook, Instagram and Twitter. ____________________________________ SPONSORS When you give a Bible through Food For the Hungry (FH), you provide a family with the Word of God in their own native language –– often a rarity! –– offering joy and hope today that will last for eternity. A Bible is not only important for providing a family spiritual health, it also offers a practical education in teaching children to read! Your gift is tax-deductible, so purchase the gift of a few Bibles for families around the world here: fh.org/bridges We treasure scripture. And we love how The Abide Bible presents it so thoughtfully and beautifully. Learn more and get a copy for yourself or a loved one here: BridgesShow.com/Abide.
Análisis de la película Señales de M Night Shyamalan con Zandy, que regresa al podcast a platicar con nosotros. Más que una película de ficción. Gracias por escuchar.
Desde Merida platicamos con Zandy sobre su película favorita de la saga de Harry Potter, esta tercera entrega es un parte aguas y cambia el rumbo de las siguientes entregas del niño mago, quien empieza a correr verdadero peligro.
Part 2 von Folge 21 geht online und damit laden wir euch seit längerem wieder zu einer Spielerunde ein. Nein, diesmal spielen wir nicht "The Legend of Zandy", sondern das neue "Tanooki Quiz", welches von Gökhan moderiert wird. Wer von den anderen 3 gewinnt? Danach wird gemotzt und gemeckert über Nintendos „Online Erlebnis“ in Form vom NSO Erweiterungspass. Zum Abschluss schwelgen wir in Erinnerungen an die alten Jugendtage, als Garagen-Bands mit Alternative Rock die Boxen befeuerten. Gebt euch die neue Folge und bleibt gesund! Eure Tanooki Bros. Intro: SVS X - Tanooki Bros. Theme Outro: Cauterize - Choke (1080 Avalanche Title Theme) Folgt uns auf Instagram: https://www.instagram.com/tanookibros Oder schickt uns nette E-Mails an talesoftanookibros@gmail.com
Episode Summary:Elon Musk Sells $5 Billion of Tesla Shares$500 Shiba Inu Giveaway Guests:Ben Rabizadeh StoryTrading 10:00Vivi Biotech Queen https://twitter.com/Biotech_SD 24:00Zandy Forbes, Ph.D. President & CEO of MeiraGTx (NASDAQ: MGTX) 41:00Ronen Samuel, CEO of Kornit (KRNT) 55:00Scott Mathis, CEO and Chariman of Guacho Holdings $VINO 70:00Renato Capelj, Benzinga, Physik Invest 110:00https://physikinvest.com/Hosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaaron BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Unedited Transcriptwe got a lot of guests today. Here's that's what I said. Here's what we got. We got Ben from story trading in like eight minutes. We've got Vivi biotech, uh, or the Bio-Queen at, uh, 1215. We've got Zandi Forbes from Mira GTX. She's a presidency yet.We're talking gene editing at 1230. We got Ronan Senor from Coronet digital we're talking, uh, fashion and the fashion supply chain at 1245. Did I get all that right? As far as timing goes. Yep. We got Scott Mathis from Gaucho holding sicker V I know, uh, at one and that Renato, uh, Capella, he is a Benzinger writer and also does some really, really cool options trading on the side.Uh, he'll be on the show at one 30. So we got what we got. 1, 2, 3, we got six guests today. We have all that's a lot, frankly. Uh, maybe a few too many, but nonetheless, here we are. So before we get to those guests, uh, we're going to talk about what's what's moving. We're going to talk about, uh, crypto. We're going to do a guest that sharp sediment.Cause we got some good feedback from that yesterday. So, um, AB where should we start? Um, well, let's start with just looking at the overall market. Spencer. I see Christian in the chat asking who do we have on for a guest today? You just ran through them, but you can also check the description in the YouTube, uh, the YouTube description for the guests for the day.Um, and shout out to the chat yesterday. We had some good trade ideas thrown out in the chat yesterday. We did, uh, easy Mike was talking about Uber puts. I played those. They were up nicely. Um, and we were talking about playing Disney for a big move on either side. We got talked out of it by our main man, Nick Shaheen.But yeah, I don't know. Maybe we should have done it. Yeah. I felt bad about that one going and they got talked out of it, but, uh, you know, it was a pretty brutal quarter. So, um, anyway, I don't even know why I look at Disney it's in my never sell portfolio. That's my first mistake is don't look at and stuff and your never sell portfolio.Otherwise you're just giving yourself anxiety. Rowan DAS pips is saying audio levels. Are we good, Bruce? Or Ron? Are you awake? I'm here. Okay. Oh, he's coming through us through the sky. I did not know that was coming from Terminator. I'm hanging out on the background, like a good idea. Hey, uh, while we figure out those levels, if you all want to do a solid, as DK suggested and hit that like button ladies and gentlemen, we'd appreciate that.Thank you very much. Um, Hey, what's do a guest, that chart segment. We're going to start doing this every day yesterday. Wasn't it easy one a B I don't even remember what it was. It was D whack. Oh yeah. That was that. That was yours. Full disclosure, I guess the one today. No, because I changed it. Shoot. So beforehand Spencer showed me the guests that chart and I guessed it and he didn't like the fact that I got it so easily.So he went out and picked a new one. I don't know what it is. I went out and I picked her from, Ooh, this will be a good drawer. And then he gets to like right away. So it's not a firms that don't get that, um, drop your answers on the chat and whoever's right. Uh, email us afterwards and we'll send you some swag.Um, here is two days chart of the day. This is going back to like February, or actually this is going back to the start of the year. This is going back to the interests of the start of the year. Now I will give you some hints because otherwise it'd be impossible. I feel like, um, in some respects, this is a technology stock in some respects.Oh man, we can have a winner already. Holy moly. Christian Gallagher. Wait, it was PayPal. This is PayPal. How so are we looking at weekly candles right now? Is this a daily PayPal has gotten beat up over the past month or so it looks like, yes, it has gotten beat up is, is, is, is a nice way of putting it, but yes, Christian Gallagher.Did anyone yesterday? No, Frendo on yesterday. Christian email us shows app benzinga.com. Hey, why is PayPal down so much? Didn't they just announce a Venmo, Amazon integration. So yeah, you would think that tell me you don't own PayPal or maybe you do and you don't know it. Um, I think in my like real portfolio, the one that I don't manage it's in there scourge.It's too easy with showing prices. Well, that's an idea. I take the price off ridiculously hard, but we could do that. Should I buy? I like calls on PayPal. No, it's gotta be coming back up at some point, right? That's one way of putting it. Um, you want to throw out like, uh, you know, you want to buy the, the, the, the, the two 80 strikes expiring and like six months.Really worth looking at. I'm sure it's not very much money. I do think though we have to, um, you know, keep up, like if we start doing obscure biotech stocks, you know, it'd be nearly impossible. So what we'll probably try to stick to, I dunno, S and P 500. Yeah. That's, that's, that's a good plan. Stick to the S and P 500.So we're going to do this everyday. Christian email us shows up and it's going to come. We will hook you up with some schwag before we go to our first guest AB I seem working backstage. Let's do our first crypto update of the day. Sure. Yeah. So yesterday Bitcoin spiked on the CPI data and then gave up all those gains and more.Let's take a look today to see how the, the crypto markets are responding to that yesterday. Uh, we, we have a lot of people in the chat that have been asking kind of how are they supposed to be trading crypto right now? So I know you and I, Spencer are in that boat where we're just like adding Ethereum and not really touching it or selling it.I haven't even added recently. It's been a while for me. I hadn't bought a theorem. I wanted the board. So yesterday, w like I've mentioned, once that CPI data came out, Bitcoin spiked and actually hit brand new, all time highs, um, gave all those gains up is currently trading about $65,000 a coin down 4.8%.Ethereum is also down, albeit not as much Ethereum currently, right around $4,800. So we talked about that $5,000 level being a big level for Ethereum. I think once we see a theory and finally breakthrough that $5,000 level, we can really see it run. Um, but yeah, everything pretty much in the red, like you can see from this heat map Sheba, he knew though in the green up 5%, um, we're actually going to have a big Shiba Inu guest on the show tomorrow.Uh, his name is Ross. He was an early investor and also a kind of co-developer of Sheba. So he's someone that I think I can say confidently knows more about Shiba Inu than 99.9% of people in the world. Um, so if you're interested in Sheba or what's next for the coin tune in tomorrow, he'll be on about one 30, uh, Spencer, any thoughts on this crypto heat map?I I'm trying to get a link right now because we're actually doing a sheep giveaway. I'm trying to get the link for that. I don't have it handy, but we're giving away some free shipping. I hope somebody gets me that link so I can get it to you. Uh, that's my thought, my thought is no. I mean, Bitcoin is an inflation hit crypto isn't inflation, hedge.Um, I don't quite understand the why it's down like this today, but you don't. All you need to do is look at the reaction to Bitcoin at 8:30 AM. Eastern time yesterday, right? Inflation comes out. It's harder than expected. It's it's more than expected. What does Bitcoin do? It goes up. Mike is saying, Hey, be it.It's a good play. Definitely go for PayPal options. Um, so I don't know if he's, you know, facetiously saying that he wants to see me lose some money, but I'm looking at him. I'm looking at the calls. Um, but yeah, Spencer, like you mentioned get some free Bitcoin we'll we'll throw that zing token up real quick.Go to Voyager. You put in a hundred dollars, you get $50 free Bitcoin, if you use the code zing. Uh, so not a bad deal at all. I mean, who doesn't want $50 of free Bitcoin checkout Voyager for that? Use the code zing. Um, all right. Real quick before we get to Ben. Yeah. Yeah. And, and I'm going to post the link to the ship giveaway.Um, when I, once you find that I find it. Yeah, no problem. Somewhere out there, easy Mick, you might be the guy who knows technicals what they're talking about when it comes to technicals, I'm watching a. Dash, which has been up a lot over the past, I don't know, week or so. Is this, is this, this the kind of subtle head and shoulders forming on the, on the one day chart?I think we're looking at five minute candles right here. I see one shoulder here. This could be the head, if this is the, the second shoulder, um, you know, could it start falling down or should I be looking at some dash puts, I need someone who knows technicals better than I do to let me know if this is, uh, you know, I'm not a big patterns guy, so I'm not really know, but we have some people out there that are outsourcing.And I know, I know when I need to listen to someone that knows more than I do. Yeah. Um, Alvin say, and he's looking at Wayfair puts an ADSL. K what's ADSL desk. Autodesk. Yeah, by the way, I just put the link in the chat for the ship giveaway. There it is. There it is. You can't click it on the screen, but it's in the chat.I'm just throwing up there. So y'all know it is there. All right. Y'all so story train. If you guys have watched a show before you've seen Ben on the show, he gave us a E H R at, I don't know, four bucks, three bucks. What does it now? It's like, I like 20 let's check real quick before he comes on. He'll give us an update on AHR.Um, it's at $23. So let's see. I mean, it's, it's up. I want to say like at least 200% since he pitched us to us on the show, he's got a couple more stocks. We're going to talk about, uh, Should we bring them on easy MC RSI? Isn't it. If the RSA is 90, isn't that a sign it could come to? I don't know. You, you know, more about technicals than I do.Let me know. All right. Without further ado, let's go ahead and get BenOh, Ben, what was the, what was the price of AHR when you first came on the calendar? What's up guys? Yeah. When I first came on, the show was around $5, five 40, somewhere that somewhere in the low fives, I believe it was. Yeah. And when we first presented it to our VIP community, when I presented as a trade idea, it was $2 and 74 cents.What, all the way up to 27. So it was a 10 bagger if you captured that. And I happened to pretty much captured that I was done. I'm handing this from 2 74. I didn't sell my first shares until 16. And then, um, I sold a lot more in the, in the 20 to 25, 26 weeks and maybe even gotten a little bit at 27. So, um, yeah, I've got a few updates for you on, on that.And a couple other sucks. Yeah. You got a new background. This is the first time we're seeing this. It looks pretty good. Yeah. A lot more work to do. We got to get that our mikes and cameras and everything, but yeah, this is the first time anyone's seen this background. Cool. And you said too, it looks like we did.It took us far too long, but we eventually got it together. You get a zoom out so Ben can see our beautiful. Oh, wow. That's great, man. Um, all right, Ben, you want to go ahead and get your screen shared and we can go ahead and run through those slides real quick. I know we only got about 10 minutes, so we've got a few I'll work.I'll be fast. All right, there we go. All right. So yeah, first we got that quick disclaimer, we got to always do that. A story is not investment advisor and missing his spirit is in most gimmick where some losses of you who are new to store trading, what is associate is the practice of understanding market pricing.We also call that the story behind the trade through the four pillars, which we say are sentiment catalyst, fundamentals, and technicals. That allows us to take a holistic look at markets and make choices based on all of these factors, not just one of them. So air story, trade idea, update. I officially opened that in my community on July 8th of 2 74, I did close it on November 8th of 25, 79.I still own some shares. Uh, I ended up selling about nine giving 95% of my shares. Um, Monday morning was really the trigger for me and that's because I saw something, the technicals and also the sentiment, which caused me to say, let me, let me lock in these games. And the technicals last Friday was the.Solid green candle on the chart, you can go look it up the first solid green channel and then tire run-up, which, which means it started the day high and then went down lower throughout the day. And throughout this entire run, it was starting low and going higher throughout the day. I took that to be a reversal sign plus the sentiment, I think when reached peak Eby sentiment for now, for this cycle with, uh, Elon Musk selling shares of Tesla with the Caribbean IPO, with excitement, but Eby infrastructure.I'm trying to time that sentiment top. So I took my profits. I am keeping about 5% of my shares because it could go much higher still if they get the right contracts in the future. Got it. Um, so it took some money off the table, trim some of your position and air took those profits, never a bad move. Uh, Ben, what else?I was on your radar today. I wanted to give you an update on side, cause I was on your show. July 26, we presented this at $5 and 70 cents. Uh, this is stuff that's been up 66% since it was initiated in our community. At the time we said, Hey, T-Mobile's come in. End of month in August. It didn't happen then.But it happened last night. Uh, so a few updates. They have earnings last year. Um, so this T-Mobile deal came three months late, but it's finally here. Now, key, this was announced last night on the conference call only. There's no PR yet. So people who are in the know who are listening to the conference call, they have a big edge getting into the stock right now.Um, there probably will be a PR at some point in the future, and there's also tremendous traction with their other customers, 18 T and Verizon. Um, there was an upgrade today to $9 and I'm not even sure that Benzinga caught it, that upgrade by the analyst and $9 by lake street. But we think in our community, it can go much higher.Uh, there's uh, estimates out there in our community saying we can do go up to a dollar 33 DPS by 2024, which would be a $40 price target. So that's the update on SSI. You know, our investigative research worked and we're read about T-Mobile just a few months late. So this company is going to start printing lots of tests going to be a very profitable company.Do, do you have a target? Um, yeah, no, I don't have to stop losses. God forbid men. No, I do stories yet. I never do stop losses. So I've been holding the stock for like two or three years. I increase in decrease my position around catalysts. So, um, I was buying and after hours last night I bought a lot more today.It's now my largest position actually. And uh, I'm not going to put a price target. I see how it goes. I, I assess the fundamental sets of metallics and technicals on an ongoing basis to determine. There you have it. Yep. So I do have a new pig that I'll get to in a second. But before that, just a little quick alert, maybe something for you guys to look into and talk about, because this is a big kind of big cap for us.At $1.5 billion company GoPro. We presented it to our community Sunday night, um, because the fundamentals are super strong. They had earnings last Friday and we have anticipated a technical breakout of the 200 DMA, which just happened this morning. And this is really, it could be a really fun situation, wanted to bring your attention because it has, this has short and gamble, squeeze potential, very high, short position.He has sense of it has been very, very low, but the financials have completely turned around with this company and they're printing tons of cash. Now you see the technicals broke. The options are very liquid, very cheap. And if it gets into the right hands and the Reddit community, et cetera, this could be a crazy profit potential, you know, with shorten game of squeezes.So keep your eye on that. But go. So GoPro's up about 9% today on the strong earnings. Um, so I, I mean, I, I don't know, personally, Ben, if I'm going to go in and try to chase GoPro and it's already up 10%, but I, or 9% today, but I definitely like having it on my radar. Uh, J rice in the chat was also talking about GoPro saying that he thinks it could be a long-term turnaround play.Uh, I don't know. Munis has been one of those stocks that has just been like beaten down over time historically. Um, but you know, at some point I don't think you can ignore the fundamentals or Fridays when I got in added more Monday, uh, I got a little bit messed up on the options than playing the options.So I actually lost some money. Cause I got scared with the whole inflation thing yesterday, but I'm in it now and yeah, the sense of it's sport, that's the only thing people hate this company, but they're printing cash like crazy. The technicals are turning and shorting, given squeeze potential, such that this, yeah, my all hold back a GoPro has always been that.I feel like they have a very limited, uh, customer base, you know, it's like who, who who's going out and buying GoPros. It's people that take part in extreme sports, you know, mountain bikers, snowboarders, skiers, et cetera, outside of that. Um, I don't, I don't know how many, you know, everyday people are GoPro customers.It's absolutely correct. And I'm not, you know, I wouldn't take issue with that, but the amount of earnings they have like 60 million EBITDA this last quarter. And if you compare it with their market cap, I mean, this thing can easily be 17 bucks. Even with that knock against it. Got it. Um, I been, what else is on the radar?I have a presence. It's my first story. Trade ideas. Since air. I presented this to my VIP community last week. Okay. Listen to the presentation. Don't just jump into buying guys. Okay. Because of what happened with their, every stocks, not air, I can guarantee you, this is not going to go a thousand percent in the next three months, like heritage.Okay. So that sock is Gaia, ticker symbol, G a I a. All right. So we're going to look at it and yeah, it's a smaller company on the ground, 200 million market cap or so, but you know, what's the story behind the trade. That's what we're trying to figure out. And again, we look at the sentiment, the fundamentals, catalyst and technical.So let's start with the fundamentals guys, digital video subscription service, like in some ways like, like Netflix, they sell, um, they make original content for yoga, alternative health, holistic healing, nutrition. It's a monthly subscription service. They've been growing steadily over the last many quarters.They're profitable. Uh, fundamentally I think their inflection really happened to a quarter or two ago when they became profitable. And you can see some of the, uh, the trends here in terms of their, um, their revenue and their EPS, although in the right direction. So in our community, we collaborate with people who are really steeped in fundamentals, just charts, courtesy of Mark Holmes.He has a risk reward chart here in terms of what is the value of this stock and. You know, it's worth, it could be worth at least $17 a share. And the stock is very cheap here. So, so that's the fundamentals. You can check it out on your own. Go look at the earnings report and you'll be able to verify everything I'm saying about, uh, the growth and the subscriber growth and money they're making written it now.And it could potentially be, uh, you know, Netflix may buy them out one day. You know, there's, there's a lot of opportunities here. So, um, yeah, catalyst let's go to the next pillar. Uh, in these sorts trading four pillars, they had their earnings just recently, November 1st, it was 20, 20, 20 2% revenue growth, uh, year to date compared to last year Q3 EBITDA of $4 million.Uh, even a margin of 20% was their fifth straight quarter positive earnings in cashflow. Um, and then they had an additional catalyst the next day. So we'll talk about that catalyst in just a second. What happened the day after earnings, but first let's go to sentiment. So the sentiment is kind of poor with the stock because fundamental investors are frustrated at the price action.I know a lot of fundamental investors saying this should be worth 17, 20, 25 bucks. Why is it $10? Why is it moving yet? So I listened to other participants. I say, I talked to people in social media. I talked to people in my community. Why aren't you interested in the stock? And this is what I'm hearing.The total adjustable market may be too small. It may be too niche, their content. We talked about alternative medicine, yoga, meditation, and things like that. So it feels like I'm just not interested. It doesn't seem like a huge part. Other people say, Hey, the content, they have some content that's kind of fringe on their French content.Like some of that alternative medicine, there might be some videos on, you know, some vaccine hesitancy type stuff or who knows, like some things are it's alternative content, right? So some ESG, uh, buyers, uh, may stay away from that environmental social governance. So that's another knock on the sentiment.The other knock is this is just slow and steady growth it's and where's the hockey stick potential on that. So just remember, this is the poor sentiment. This is what happened. Going back to the catalyst the next day after earnings, after we know the fundamentals are great, the next day another catalyst hit the other, the catalyst was there was a PR that Demi Lovato became a brand ambassador for.And there was a press release that a lot of people didn't see a where Demi Lovato says I'm excited to be one of Dias. First celebrity ambassadors, and honor to join a platform. I've been a fan of for some time she has 118 million followers on Instagram. And the market cap is again like 189 million. So this company has been growing slow and steady.And all of a sudden, they hit you with this news of Demi Lovato is a huge mainstream personality, that and company, I want to go back to this. Airpoints the one thing I saw that the thing about Demi Lovato, uh, in, and I, I guess I didn't realize this was the same company, but like they got a lot of weird shit on their platform.And that was the sentiment I was talking to. They're saying, oh, there's stuff is weird. I just don't want to own this company. But you know, I think that, you know, they're growing steadily, they're getting to a place where they can really focus on growth now, and to me, and let me go back to that bad point.You just made that pinpoint. You brought it up for me, right? Yeah. They have weird stuff. It's too niche. The French content. They keep some buyers away. But this is where I think that Demi Lovato news is really significant because they're in a financial position now to really grow the company. And to me, this signals.And in fact, in that PR said, I'm excited to be one of guys. First celebrity ambassador, And I have a feeling this company is going to start growing their content and start getting into more mainstream content. And based on what you're saying, I think they may be looking for more celebrity ambassadors.And it's just a great situation because the downside is so limited. You have a fundamental floor here and now you have optionality upside. If the company starts doing things to get that hockey stick growth potential. And that's why I really add it to my position here. And I'm very excited for the next several months on this stuff.Um, let me just go to the last or technical resulted with her awesome technician Rex. And this is a monthly chart is saying, uh, this can go to the twelves if it breaks out of the yellow.here, which thought is that shorter than I think the current breakout circled right there. It's got a breakout of, I guess, 10 70 area.He thinks it can go to 12 for the month. And here's another view which looks much more bullish. This is a long view of the monthly chart is a sometime in the future. When the 12 to 13 breakout at the blue line, it should proceed to break out the all-time trend at the white line. And he thinks this is a several month play for that to happen, but you can kind of see where this can go.Uh, if that happens. Uh, any questions on that or any of the other stops, man? I didn't see this one coming. I didn't realize this. I read about this company and I was like, man, I didn't even realize they were a public company until you came on here. So, um, I'm all I'm putting two and two together here. Uh, Ben, thank you as always for coming on the show, we appreciate it and uh, and have a good rest of your day.Please follow us on YouTube. Thank you guys. Thanks a lot, Dan. We got to get moving. We got our next guest. She's already here. We're going to talk biotech guys. I know that we, we always get asked. We always get questions like when's Vivian. When's Vivian. When well she's on right now. Not right now. She'll be on in like five seconds when we bring her on.But Vivi Bio-Queen will be joining us every Thursday. At this time, I told you all to save your questions for your bites. The questions for right now, let's bring her on Vivi. How are we doing today? Good. How are you guys? Can you hear me? Well, we hear you. We see you and we have questions. Oh, awesome. And before we do any questions, I think, um, we can do some updates.I did have a request on Twitter to cover it stock. Um, like at my old good lawyer friend, mellow at Twitter, I, this is out for entertainment purposes. So, uh, is only my opinions are for entertainment, purpose, not a financial advice. So I wanted to, uh, first of all, um, talk to you guys, um, just given up a date, we just had the, uh, ER, on KMP.H can you guys put that up over there? Yeah, this is a daily chart. Okay. And P Hit's quiet. So, yeah, so we just had the ER and I want to, so when I, when everybody kept asking me, like, what do you, what are you going to do for 'em? What are you going to do for K MPH? My position was this small because he is a, some of the concerns I had. I spoke to the manager and he interviewed me. And, uh, he said, you know, we're not going to put any reps in New York yet.And it's just going to be certain regions in the United States. And for me, it showed a little bit of a weakness because for me, if you launching a drug, you should have put reps all over the map. But I think they're just trying to be cautious. So they report around like, I think 2 million in revenue, but here's what I'm bullish.Now. They just launched the rest of the Salesforce. And this company here, you know, their burn rate is really, really small because Korean is doing all the selling. So the burn rates is like a million a quarter and they have a, still have 135 million. And he is what I'm bullish of. Um, there's a company that sells a scripts and there's a guy that, uh, his friend works for this company and feeds him all the script.So for you guys to have an idea, right, the, the feedback has been amazing. So July, they had a nine scripts for the monthly and then August, they had 173 scripts, um, September 416, October 886, still low because there were not out throughout the nation. But I think the feedback has been tremendous from psychiatrist, from the drug and the differentiator.And I feel like as they deploy, uh, the other sales reps, we going to just ramp up the sales. So I feel like at this moment, I wanted to add a little bit more to my position because I, I see the future being very bright here, KMBH. And I think that, um, we gotnot yet. Not yet. I, I should have now I have an, I am waiting for some of my swings to flourish, so I haven't been able to, to add, but I wanted to for sure. Okay. And then I want it to put you guys out. Somebody asking me to, uh, to, uh, cover a, uh, a N N S. Hmm. Okay. Now I want I'm familiar with, but it is biotech.So it's a biotech it's under the radar. So I wanted to explain to you guys some of the reasons how I invest in biotech, and I told you guys, if there's no commercial products, there's, there's got the most important thing you can look at is cash, right? Because if you don't have a cash, no product, are they going to burn too much?And they also gonna have a, to do offerings. And if the stock is low, they do reverse the split. So the first thing I do is to look what was the cash burn and how much cash they have left in a would the future and what the catalysts are going to be. So this company here, the first thing that got me to, to look at it was they have a $271 million in cash.So they're really the city really strong. So I thought that was a really, really, uh, um, uh, valid, uh, information, very important. Then I look at a financial institution on. EVestment, which is a goblin, was the director of FDA is a partner on their firm. So they own 2.5 million shares. So I thought that was another very important information because goblet is well connected to FDA.Not that you know, it nobody's going to be bought out, but when you have investors that work with FDA, they know what it takes to, to be compliant, to get a drug approved, right. Because it's just so much behind to get a drug approved. So manufacturing, you know, how the studies are designed. So I like the fact that there's Nia investment behind.And then I also know VOD is, oh, 2.1 million. So Novartis has some interested and, and the pipeline, it looks really, really amazing is all CNS, um, uh, and mass. Um, they're going to have, uh, Gilliam Barre syndrome, which is a very rare disease. So I really like this company. I really do. I, I'm not, uh, obviously I can't be in every single stock.Uh, but I, I, I, I think this is a really good a long-term, uh, stock to hold for sure. So that would be one. And then if you can, um, bring back, uh, pro GPRO G we have a lot of fans PRG. It's like almost like a min stock, but also a really good stock to hold long and, um, really. Yes. Yes. So, so what, what do you see that the market doesn't see, um, what I see that the market doesn't see.Um, I will tell you why this company is going to be huge. They have a two types of, of delivery system. They have a, um, on, I'll tell you guys, they have a two to two technologies and I wanted to bring to you guys, let me see. I can share a screen. Okay. But I have it here right in front of me. So they have two things.They have the OBDs okay. Which is oral Biotherapeutics delivery system. So what it does is, is able to take big formulations and put in a form of a pill. So for example, Humira is one of the biggest blockbuster drugs in the world. If they found a $10 billion. So you imagine if Abby, I think Abby is a Humira honor.If, imagine if Humira is loses patterns and five years, right. And all of a sudden, because doctors love the efficacy of this drug, and that's why it's so well prescribed. Right? But it's an injection. Imagine for this company sell their technology. And all of a sudden you can have a drug, like a Humira being, um, given orally, all of a sudden you create a whole new patent for that drug.Do you follow me? Because a different formulation. So all of a sudden you gaining another 15, 20 years. I have a patent on that drug. Now imagine how many pharmaceutical companies would have be jumping all over because they like, geez, I have this, this drug that's high formulation. And now I have a, I would love this drug to be an oral form because patients do prefer to be an oral form.So I see, um, they announced that they have three partnerships with the big pharma, but they have announced who, so everyone is kind of on a suspense, like who are going to be the big pharma. So they have, uh, right now with the Pfizer there, just to have an idea, they, the not only the delivery, the delivery system does this to the big formulation, but also one of the drugs of four in any boat to the second one, the oral bio biotherapeutic delivery system.The OBDs, what it does is it's designed it to, to, um, to take it a pill and the pill, the way this delivers it, doesn't go all over your bloodstream. So it's it's for the GI tract. So is GI specific drugs and there's one. For for, for, uh, uh, Pfizer they're there. The preclinical, what they found was not only that, that would their delivery system, that drug was 25 times more potent than the Pfizer drug, but had a no toxicity because it doesn't go to the bloodstream.Like the other drugs would go. So you have a less toxicity, less, less side effects. So imagine what they can do if they already doing this with Pfizer drug, they're studying the Humira. Imagine like for me, this drug should have just literally like get royalties for every farmer, choose the technology instead of it being bought out.Right? So I believe this, the future of this company is super, super bright. Uh, you know, it's heavily shorted. So I think that a lot of people are here for the, the, the, the gum is squeezed because if you look at the amount of, of, uh, of, uh, options, that the options chain is crazy, uh, for this, for this company.But I, I will, like, I have a big position because I wanted to, you know, to trade around my core, but it's some, it's a company that I wanted to keep it. And, um, and a long term, uh, option, because I feel this company is going to be huge. So they just appointed also geo hall, believe it or not do, how do you, how, um, she's in a board of directors and this woman, it's like a powerhouse in biotech, a friend of my work.As so maximum, so messenger gas sold. So she comes in with a lot of experience in pharma and a lot experience in acquisition. So, uh, the team is fabulous. They are four miles away from my house. I should have just bring them a bottle of champagne when we hit $10. But I believe in this company, this company has a bright future and that, um, right now there's a lot of people on it, you know, waiting for that short squeeze.But, uh, it's been keeping really it's being holding like it dipped to, to like 2, 3 0 3 today and it went right back up. So it's been keeping, you know, I think the short sellers were expecting after der cause you know, there's, you know, a yard for a state, uh, initial stages of biotech doesn't produce revenues.Right? So it, it dipped to fund 360 2 all the way to three, but it's been holding for weeks at that average. So people are not selling people believe in this company for sure. Uh, can I ask you, what do you, what do you get, do you have any favorites in the, in the gene therapy space? I do. I, um, I, uh, I, I'm a loan holder for ADP and they have the, uh, it's one of the car T therapies, but it's not the car T is the RTC, uh, ADP.And, uh, the reason I like this company is, uh, not only they have a partnership with Genentech, uh, the Genentech partnership is up to three. And, uh, they already have enough funny from Genentech cause they got, they gave them a prompt payment payment. They have funded into 2024. So I feel like this is a very safe play in regards to not having offerings and that they are sitting with 285 million in the bank and they do have, uh, some, um, some, uh, catalyst coming.And, uh, I, I believe this company will be a multibagger on day, you know? Uh, so it's one of those that you set and forget it, but I like the position of cash because it gives me the comfort that they're not going to be throwing in offerings after a big catalyst. You know, they, they have they're in a really strong position.And when you look at, uh, um, institutional ownership matrix, all 15 million shares of this company, baker brothers owned 18 million, the institutional ownership. It's so strong in this company. And obviously Jen at that has a huge, huge portion of the company and has their eyes on the company. So, uh, this, this is a big one for me.I got to ask you about, about BCR X here. That's the rule. Every week we got to talk about BCR ex of course, it's this year access to my unicorn. You guys, for sure. So, um, it's, it's funny. I held this space as on Twitter yesterday, and I was talking to a pharm D you know, I do respect, they have a lot more knowledge than me, you know, uh, in terms of a clinical.And he validates my position on the CRX and GRTs, which is great stone. And he says to me, you know, be CRX is, is a rare diseases monster in the making. So they, um, they just released the earnings. They put 38 million for the quarter, and people, BU people were really upset that it wasn't 7 million like this huge numbers, but for the mentally long-term, it's still there, right.Because the science hasn't changed. So I see this as an amazing opportunity, uh, if you're not in the CRX, but, uh, just, you guys have an idea. Uh, the biggest drug for, um, for Alex yawn is, uh, Alto Morris. And they are not even that good because it's not only an infusions for PNH, but patients still need transfusion, uh, taking this infusion every eight weeks.Uh, BCRA X has the competitor, which is going to be an oral oral, uh, competitor factor D and not only patients that have been on this study up to now, not only they jumped from phase one to phase three, because they did so. Patients to this date. I think there's 40 weeks, 30 weeks of, could it be this fusion to this date?So imagine having a drug that is, it's already a rare disease for PNH and patients only at the choice on the available is in Jackie, no infusions. And you still have to go through the transfusions. Imagine having an oral pill that you don't have to have a transfusion at all. So just make them do the math and Alex, the on 70% of its revenue, 70 was on PNH for this drug and they got bought out for $39 billion that would have put the CRX at a $230 a share.And B CRX has a better pipeline with a more potential and it's going to be all oral. So you guys do the math, if you don't think this is a monster in the making. Alright, Vivi the bio queen, she joins his every single Thursday at biotech. Underscore SD is for Twitter handle it's up on the screen. And uh, and then please.Yeah, please, if you, I will post my DD there because this is a very short, so you guys searched the bioclean on Twitter and you can find me all right. Thanks a lot. Viva, talk to you again next week, next week. All right. Uh, Hey, let's stick with biotech for a second here because our next guest is the CEO of a gene editor.Company, hence why I asked to VV about that one to get her thoughts. So, uh, if we can, let's go ahead and, uh, and, and, uh, bring her on guys. Andy Ford. She's the president CEO of Mira GTX. His company is a lot going on right now. They're at a very critical point. So let's get Zandy onum, Ford,by the way. Yes. Thank you. Thank you. Where we're actually, it's on our to-do list to get new music, but, um, thank you for, for, for the compliment. Uh, so as I said, it's a pretty critical time for, for mirror DGX. Uh, you guys just presented at, uh, uh, the virtual, uh, oh gosh, uh, the European society of gene and cell therapy Congress, right?Uh, yes, we did add three abstracts. Yes. Right. And then there's a, we're due for another, a little bit surprised when I found out you're on the calendar. Cause I thought you guys, you have another, uh, presentation coming up in a few weeks. I, I, I think I believe right. We do. So we have, um, quite a number of presentations in the second half of this year, uh, which included, uh, some presentations at the meeting.You just mentioned on our programs and our switch that allows you to switch gene therapies on and off with a pale. Um, related to what video was just talking about, actually, that's what I do want to talk about. I'm sorry about, and then, uh, at the beginning of December, we, uh, having a clinical update on our xerostomia program for patients who've been cured of had a neck cancer, but don't make saliva.So we'll be completing that study this year and we'll be updating on the clinical progress so far at the beginning of December. And then a couple of weeks later in mid December, we're having a science day to discuss in some more detail, uh, Ribas switch technology and our promoter platforms, which allow us to really optimize gene therapy.And for the first time switched gene therapies on and off with an oral drug and not just switched them on and off, but quite precisely dose the amount of gene therapy at a particular time with a dose of an oral pill. So let's talk about the switching via via pill. Yes, exactly how that. So obviously gene therapies are a virus which contain a gene and there's a coding sequence of the gene, which will make your protein, whether it's Epogen for example, or whatever, uh, gene therapy, it might be RPG or for the eye.And that gene is activated by a promoter, a regulatory sequence at the beginning of the gene. So that's the normal gene therapy promoter and a gene, the promoter switches the gene on, and it remains on for the rest of that patient's life, all that sells life. So you have persistently expressed gene therapy, but what we've been able to do for the first time is we do everything.I've just told you with the promoter that regulates the gene therapy and switches it on. But on top of that, we put into the gene sequence, a small sequence of DNA, which instructs the entire RNA produced from that gene to degrade. However, if we give a small molecule, but via pill, and we've got many small molecules, because we've developed this as a platform, it stops that degradation.It cuts the entire degrading sequence out of the gene. Produced RNA and you'd get the gene switched on as if it was never there. So for the first time we can deliver gene therapies, which are not on, so they're not producing weird proteins or bits of proteins. And we give a pill and bomb that I'll call it.The degrading signal is cut out of the RNA and you get a perfectly normal protein product.I guess I have so many questions. I don't even know where to, I like that all sounds incredibly complicated. Um, I guess, uh, how can you make sure that it works? So it's, we've when we set up the company, this was one of the technologies that we, um, we wanted to build and these switches made of RNA shape.There are thousands of them and bacteria. And for, for decades, people have tried to take bacterial switches and make them work in human cells. And rather than doing that, which hasn't worked very well. We built, we use the theory of Reiber switches and we built based by base our own switch. So we built it in mammalian cells.We then tested many switches and we have a platform of switches we can control. We were able to make these really simple switches, which switched on and off to high dynamic range. So 5,000 fold above the off level when they're switched on. And as a consequence of that, we were then able to change the drug that we activated with.So now we have multiple genes that we've put our switches in sitting in our freezers. So, uh, various antibody, PCSK nine antibody. You'll be aware of, uh, PD, one antibody, the, the very large drugs we can regulate. And then other drugs like GLP one, obviously a diabetes and obesity drug, which we can regulate.So we've got those genes and we can now put them into vivo in mice and NH PS, and we give those animals small molecules and we've already shown. Based specifically on the dose of the small molecule, we see our drug switched on to exactly the right level in each animal, depending on the dose of the small molecule you give.So we have built this over the last five years and we have moved from cells to mice, to non-human primates. And we're currently in a position to start doing I N I N D enabling studies for both the small molecule, all drugs and the genes that they regulate. Uh, and then as far as use cases, I know you're working on, um, you know, you're working on applying this, um, to, uh, I disorders, right.Uh, but is that the only use case right now? Tell us about the other one. No. So, um, we developed this technology of controlling gene therapy with a pill in order to much more broadly open up the space that gene therapy could be used in. So. We do have a lot of expertise in the eye and a partnership with Johnson and Johnson for our rare eye disease programs, but in diseases like wet AMD or dry AMD or uveitis, those large diseases.These are targets for regulation with our cassette and small molecules. In the case of our wet AMD program, we inhibit VEGF like other companies do. But what we're able to do potentially is when we put that gene that blockades by Jeff into the eye, we can formulate one of our small molecules. That's otherwise oral into eyedrops.So what we're working on now is turning our small molecules into eyedrops. So we can put a wet AMD drug or uveitis drug into the eye as a gene and switch it on each day with an eyedrop. So the eye is an excellent place to be able to regulate gene therapy with a small molecule, another place, which is really important is in the brain because it's very difficult to get antibodies or biologics across the blood-brain barrier.But what we're able to do potentially is we have regulated antibodies and we can put the. By an injection into the brain, just a one-time injection within the blood brain barrier. And then all you need is a pill which crosses the blood brain barrier. So it allows us to deliver drugs that really hard to deliver by other routes.And there are many, many more applications. It, it hugely expands what you can use gene therapy for, because for the first time you can control how much you gave. And at what time, uh, it seems like broadly speaking Zandy, um, gene therapy, like what, like as an investment, it was like super sexy a couple of years ago.Right. And then it sort of, it was super hot and then came down a little bit and was like, oh, wait a minute. This is still really days. Where, where are we now? Are we like back to, is gene therapy being like the hot, the hottest topic in biotech? Or, or are we still sort of, is it like the off cycle? I dunno how else to phrase it?W well, I think there are, there are many different gene therapy companies and there is cell therapy companies. There are very, very large number of, of, uh, therapies in the genetic medicine space. And, um, and there are some companies that just have a product or a platform or a particular organ that they focus on and that.Is a somewhat higher risk to those companies that depend on data around a particular study, right? What is quite different about mirror is that we established the company to really innovate in gene therapy and shows indications in the clinic that had good proof of concept and highly likely to work and to support a future pipeline.We built everything you need to be a gene therapy company in-house so we have multiple promoter platforms, multiple capsid discovery efforts. We have our own internal manufacturing, which is probably the broadest engine therapy today in that we manufacture our own GMP plasmid. We have two, uh, viral vector manufacturing facilities, which are flexible and scalable to commercial scale.And we do our own QC and analytics as well as potency assays. So we have a very, very broad, I suppose, toolkit that's required for anything. That you need to do in gene therapy and went out, positioned with this regulation ability with a deep pipeline of regulated genes that we can then take through to the clinic with our vector ecology and our own GMP manufacturing,not of the regulatory by putting all that in house. I was just gonna ask, as, as we get more developed in this space, like Spencer said, it seems like a couple of years ago, you know, that the gene editing space was huge for investors. Uh, what advice would you give investors that are looking at different, uh, you know, genomics companies to, to be able to discern which ones are going to have an advantage in the, in the field once the industry does become more hot among investors?Again, I do think that right now, manufacturing is not just a bottleneck with respect to capacity, but, um, Dealing with regulatory agencies globally and an expertise in manufacturing process. And, uh, and the assets required to show the release and stability of your products is very, very important. And to be able to either have that, to have as much of that as possible in house dearest clinical programs that you'll see, particularly if you have those sorts of capabilities at the time of D you really don't want to see companies that are starting manufacturing their product in one way.And then at phase two, switched to another way and then have to scale it later. Ideally, you would look for companies that have capabilities that allow them not to necessarily rely on CRS for plasmid manufacturing or in DQC. And we learned that over the last five years, it's one of the reasons we've bought, uh, so many of these capabilities in house, but I do think that's very important.Um, in addition to obviously, you know, do the targets work or is this, is this an appropriate, um, disease for gene therapy, the nuts and bolts of being able to produce and show the agencies that you've produced the right thing, a really important. Zanni Forbes is the presidency of Mira GTX. As I mentioned, there's a lot going on.You guys also got some positive in Canberrans over the weekend and, uh, uh, a lot of presentations after being in stealth mode for quite some time. So, uh, looking forward to seeing how things develop here and, uh, and, and, and good luck going forward. Thanks a lot for coming on today. Thank you so much. All right.Hey, w we got to keep the train running on time here. We've got so many guests today, back to back to back to back let's pivot. If we can, maybe we just spent the last half hour or so talking biotech, uh, let's pivot to like supply chain, specifically, uh, supply chain of textiles, right fashion. And what exactly is going on there?What to find out? We're going to bring on our next guest here in just a second and running Samuel. He is the CEO of a cornea technology, and, uh, let's bring coordinates and a Ronan. W that's been running on this show. Now, if we can guys, I guess I'm Spencer, I guess I'm doing that. All right. I got you right.There you go. Good morning for us this afternoon for you it's later on in the evening. So I appreciate you, uh, coming on, uh, the, the, uh, the show here today. So, uh, let's talk about textile supply chains, right? Uh, what exactly is going on there right now are things as bad there as they are in other areas of the.Well, um, yeah, it's bad. And it has to change the supply chain is broken, but even more than that textile industry and fashion industry in particular is the second most polluted industry in the world. Um, from different reasons. One of the reason is that 30% of whatever put use on textile is actually never been sought.Uh, and this create a huge amount of waste, both of materials and water, and we have to save the world. Um, uh, so we have to change the industry. Now, the reason for that is some of it is because the supply chain of today doesn't meet or doesn't fit the need of the consumer of today. The supply chain of the textile industry is like centuries ago, you produce in large quantities in forest, in China, in Magilla dish, you trying to forecast what the consumer, what the people would like to buy a year in advance, sometimes 18 months in advance, which is impossible.It's crazy to think that you can predict what the consumer today would like to wear in a year and a half from now. So we have to change it. The world move to digital in many, many industries. And in this industry is still fully. Yeah, I'm glad you brought up the, uh, you know, the environmental impact of the textile industry, because that's something that's gained a lot of attention over the past year or so.I mean, you have a quote unquote fast fashion companies, such as sheen and people have kind of started attacking the, the idea that, oh, buying, you know, a cheap t-shirt for $15 or some pants for $15 that you see an ad for an Instagram, uh, causes a lot of environmental distress. So what do you think needs to be done in the industry to address that?So they, this would need to change in order to try to predict what the consumer would like to buy and put, use Lauder moms of products, which will never been sold is to produce, to demand, to produce after the consumer.But that's not efficient. I mean, it you're saying it is, but that's not a necessarily inefficient use of capital though, right? No, no. It's, it's actually a very, very efficient, um, hold on, explain to me, explain to me, yeah, let's begin with, first of all, what we see that production is really moving on shore.Why it's moving on shore, not only because the, the, the supply chain is broken because you have to be closer to the consumer. You have to react fast for the consumer trends. Now, the world of fashion and textile move is moving online today. 30% of all purchases being done online. So e-commerce the focus by 2025, that it will be more than 60%.Now, the online the e-commerce of today is still trying to sell you what they have in the inventory or what they have in the shops, in the stores. Uh, and if you going to order products, sometimes it does not exist at all. Um, and uh, sometimes, um, for the brands is really, really difficult to. Okay. Can you hear me okay?Yeah, we, we, you we're fine. We just got disconnected, but we're back. Okay. So, so I missed everything you just said. Okay. Okay. So let me try to explain again. So the world is moving digital. What does it mean? The consumer today's buying? So e-commerce online. 30% of all sales is being done online and the focus by 2025, that it will be 60%, but the online is today's actually a mirror of the store.Doesn't allow you to choose your product. They're trying to sell you what they have in inventory, which doesn't fit what this consumer would like, what we believe needs to be done, that the online should be filterable. You shouldn't have any real physical products. You can have endless amount of product virtually and connect the virtual wall to the physical world.And this is exactly what committee's doing is enabling on demand, production. You order what you want only. Then you produce it. You produce it close to the consumer. Onshore and delivering, you know, the same day on the next day to the consumer, the product, I feel like this is I'm in now. It sounds great. I think that, but that's like, that's more difficult, right?Well, I give it a few examples. Well, one example, great example. Thinking about the books book markets, um, back at 25 years ago was fully analog. You went to a bookshop, you tried to buy a book. You only have them, the shelf, the books that we're selling in millions of copies, Amazon disrupt this market. They created a digital world.You could go to Amazon buy any type of book, even from 200 years ago. But what they create is actually much more, the impact was much more than that because now everybody can become a writer. You can write a book about your family, about cooking, about anything you like, you publish it. Virtually doesn't cost you anything.Only when someone is ordering, then you print it and send it to the consumer. So the same thing is happening now in the fashion world, you don't need to have it physically. You actually unleashing creativity because you can have endless creativity and each one of the consumer can choose whatever they want in any Colleen, any design.And once you choose it only, then you produce. So this is efficient and there is no way. And you produce it using coordinate technology, which is a fully sustainable green technology. That was my next question was just if you to clarify that, so I come up here like Amazon, for example, uh, could have used your technology, right.Or, or any retailer, right? Could just buy your technology and, and use that along their supply chain to make it more and more green, more efficient. Right? Actually, Amazon is our biggest customers. Okay. Amazon is our biggest customer, but we have many, many more customer. We are worth more than 1000, 300 customers that using our technology all over the world.Some of them very big companies like Amazon, like Adidas, like fanatics, but using our technology. And you can go online and order products and customize the product and order your t-shirt here. You can see with coordinate on top of that or on any color, any size, any shape. And this is the new world. Look what the world is moving into.What is moving into metaverse. So metaverse is everything is virtual. You will have. Your image in the metaverse. Yeah. You will be able to dress it as you wish with any, any type of, of, of goods. Uh, and only when you feel that you lack it, then you order it and then it would connect it to the physical world, which will be big produce next to you.If you are in New York, it will produce in New York. If you are in Beijing, will be produced in Virgin and shipped to you the same day. So the impact on the environment in terms of sustainability is huge and their efficiencies and believable, and the creativity is unleashing the creativity for the designers and for the brands.W why is no one else doing this? Or are they well, uh, there are some, uh, companies, our customers that using our technologies like Amazon are doing it. If you go to Amazon and you're doing what you're doing, right. That's what I meant because, well, we are kind of unique festival in terms of the physical world.We out technology, what we have developed is systems Inc services that is all sustainable, which are digital systems that can produce one off. If you want it to produce a t-shirt or any, any government or any fabric in the, in, in the past using analog technology, you had to print where to produce hundreds of meters in order that it will be economical and.The sustainability impact is huge. Um, there's a lot of pollution and consumption of water for every meter without technology, because it's digital, you are not limited. You can print one t-shirt, you can print one meter, one fit, there's no limitation and every feed can be different design. So this is the advantage of digital is unleashing the limitations that you had before, and we are not using water.So there's no, there's no water consumption. It's pigment ink. So it's fully green. So no impact on the environment. So like who couldn't use corny Amazon obviously, but they're the largest retailer in the world could, could, could I use it on my online Shopify store that make, that sells? I dunno, 10 shirts a year.Exactly the point it's off form. The biggest retailers, biggest e-commerce biggest brands like Adidas, Nike. They of course can use it to anyone, any consumer that would like to open a shop in Shopify. Now, what is the problem with Shopify? If you are now at this time? And you see somewhere in India and you would like to, to sell your product.You open the shop in Shopify in five minutes, you put your design, what is the problem? Once you get the order, what are you going to do with it? How are you going to produce it? Are you going to ship it out? We can compete against other marketplaces. What call Nita Naples is to connect all those and marketplaces all those designers in to a network of fulfiller that can fulfill for them.So you need to take care of only on the design, open a shop, and then connected to Coney ticks. And kinetics is a platform that connect them to a network or fulfiller that using our technology and can produce it anywhere around the world. And it sounds good. The market clearly likes it. Cause if you, if you look at your stock, it's had a pretty tremendous run actually, even, even last year, uh, seemed to, uh, COVID, didn't seem to hold it down too long.So, uh, the market agrees with you. Uh, so I, I guess keep doing what you're doing. Uh, running Samuel was the CEO of, uh, coordinate, uh, digital. Uh, we will have to get you back on the show. Uh, hopefully, uh, now maybe next year when, when the supply chain starts to work itself out a little bit, but I, I I'm, I'm very curious about this space because, uh, you're, you're one of the best performing stocks, uh, I think out there probably right now.So, uh, Ronan, thank you so much for coming on the show today. Thank you very much. Pleasure being here. All right. Uh, it is, uh, 1259. We've got our next guest coming on in couple minutes. Whenever minute when it, whenever they join, to be honest, cause they're not even here yet, but that's okay. Uh, Scott Mathis is the CEO and chairman of Gacha holdings, ticker V I N L a.And then we have, I'm very excited for our one to 30 guests, but we're not a Capels from Benzinga and, uh, really Benzinga is, is a side it's his side gig. His main gig is, uh, is doing really complex. Trading stuff, strategies. So, uh, I'm, I'm very, I'm very much looking forward to that, uh, in a half hour. Uh, if we can think of who executive though, and I have not grabbed, voted for likes yet this hour as we enter our two of our show keyword yet, uh, if you could be so kind and hit that thumbs up button on your screen, I'm not sure where we're at on the light counter right now.Let's look, we're at the de come on computer 74, 75. We can do better than that. We do over a hundred easy, easy. The goal for the goal for the day is 200, but we can get you a hundred right now. I suspect. Yeah. So before we get to Scott Mathis with a wild show holdings, um, the, uh, the previous guest, I liked that idea of cause basically what he's saying is that companies now are producing clothes for a year down the line, right?But they don't know what's going to be hot on Instagram and Tik TOK and what the trends are going to be efficient. It's not efficient. So what, what he's saying they're doing is waiting and basically it's print on demand, but on a huge scale, like what Shelly was talking about in the chat with the economies of scale, they're able to produce, uh, the goods for cheaper when they're doing it on a large scale.If everyone, if they're, if their technology is able to kind of shift that whole industry, it would have a tremendous impact on, uh, the environmental right now, the negative environmental impact that the textile industry has. Another fun fact. Spencer, did you know this, that a lot of luxury brands, um, such as, you know, Gucci, Louis Vuitton, do you know what they do with their extra extra goods?No, I don't want to say something that's politically incorrect, but I know I have no idea. What could, what would the, I don't know. They, they, they, they give it the, give it to animals. I don&
Keyan Zandy is a longtime Lean practitioner, enthusiast, and advocate. As Skiles Group's COO, he has a dual focus on client service and on nurturing a progressive company culture. He is ultimately responsible for the oversight of the firm's daily operations and ensuring that their Lean processes are continuously improved and consistently practiced. He is the co-author of The Lean Builder: A Builder's Guide to Applying Lean Tools in the Field, which simplifies and clearly articulates the benefits of seven primary Lean concepts, and delivers them in a highly-relatable, immediately-applicable, and field-friendly manner. Keyan also holds a patent for an award-winning crisis management communication and emergency response tool called Smart Safety where he serves as CEO.Watch on Youtube.
“My husband isn't my enemy; he's my person. Remember the kind of marriage you want in the end.” I want As a millennial, Zandy Hicks has a passion to see her generation understand God's design for marriage and have a strong marriage that lasts. As the host of the Bold, Brave and Daring Podcast, she shares boldly about how we can live in today's world with confidence and grace. For more information on Angela Donadio: The podcast now on the Charisma Plus App! When you sign up for the FREE app using my personal link, you help support this show and bring encouragement to listeners in more than 130 countries! Bphttps://play.charismaplusapp.com/subscribe?code=AngelaD FREE resources, Join Angela's Online Community, Find her Angela's books, albums, and links all in one place! https://www.angeladonadio.com LISTEN to the Make Life Matter Podcast: https://www.angeladonadio.com/podcast WATCH Episodes and Clips: https://www.youtube.com/user/AngelaDonadio CONNECT: Facebook Page https://www.facebook.com/AngelaDonadioVOV/ Instagram https://www.instagram.com/angeladonadio/ Linked In https://www.linkedin.com/in/angela-donadio-58019338 INVITE Angela to speak: https://www.angeladonadio.com/contact
Keyan Zandy, Chief Operating Officer, and Joe Donarumo, Senior Superintendent, authors of The Lean Builder joined guest host, Jesus (Jesse) D Hernandez Jr, The Learnings and Missteps Podcast, and Felipe Engineer-Manriquez to build out a dialogue about why they wrote the book, why the industry needs more collaboration, and what we can all do to make construction easier and better today. The Lean Builder is a story and playbook for builders by builders. It features a fictional tale about a newer general contractor superintendent tasked with running the most complicated project of his career. The story includes the all too common challenges in modern construction — lack of communication, coordination, and waste. The story comes to life with dialogue among the characters including a mentor that shares Lean Construction experiences, tools, and processes to help. The book's second part includes a playbook for Daily Huddles, Visual Communication, The “Eight Wastes,” Managing Constraints, Pull Planning, The Last Planner System™ and Percent Plan Complete. Books Noted: The Toyota Way: 14 Management Principles from the World's Greatest Manufacturer By Jeffrey Liker The Goal: A Process of Ongoing Improvement By Eliyahu M. Goldratt and Jeff Cox All I Need to Know About Manufacturing I Learned in Joe's Garage: World Class Manufacturing Made Simple By William B. Miller and Vicki L. Schenk --- Connect with Joe and Keyan at The Lean Builder Website at https://theleanbuilder.com/ Connect with Jesus (Jesse) D Hernandez Jr via The Learnings and Missteps Website at https://www.learningsandmissteps.com/ Connect with Felipe via Social media at https://thefelipe.bio.link Subscribe on YouTube to never miss new videos here: https://rb.gy/q5vaht --- Today's episode is sponsored by Bosch RefinemySite. It's a cloud-based construction platform. Bosch uses Lean principles to enable your entire team, from owners to trade contractors – to plan, communicate, document, and execute in real-time. It's the digital tool that supports the Last Planner System® process and puts it all together in one simple, collaborative ecosystem. Bosch RefinemySite empowers your team, builds trust, creates a culture of responsibility, and enhances communication. Learn more and Try for free at https://www.bosch-refinemysite.us/tryforfree Today's episode is sponsored by Construction Accelerator. This online learning system for teams and individuals offers short, in-depth videos on numerous Lean topics for Builders and Designers to discuss and implement, just like on this podcast. This is tangible knowledge at your fingertips in the field, in the office, or at home. Support your Lean learning at your own pace. Learn more at http://trycanow.com/ Today's episode is sponsored by the Lean Construction Institute (LCI). This non-profit organization operates as a catalyst to transform the industry through Lean project delivery using an operating system centered on a common language, fundamental principles, and basic practices. Learn more at https://www.leanconstruction.org Today's episode is sponsored by STRUXI. STRUXI is happy to help the EBFC Show fight the good fight for improving construction productivity. Built on 50+ years of construction-tech innovation, STRUXI replaces outdated-paper timesheets and production reports with software that updates you on labor productivity in real time – without disrupting how you already run your job sites. STRUXI does this by providing a simple user interface, so your foreman can accurately allocate time without being stuck behind a computer. This data is also easily connected to Power BI for rich reporting and forecasting. Learn more at https://www.struxi.com/ The EBFC Show Intro Music: –––––––––––––––––––––––––––––– California by MusicbyAden https://soundcloud.com/musicbyaden Creative Commons — Attribution-ShareAlike 3.0 Unported — CC BY-SA 3.0 Free Download / Stream: https://bit.ly/al-california Music promoted by Audio Library https://youtu.be/oZ3vUFdPAjI ––––––––––––––––––––––––––––––
My guest Zandy Mangold is a New York City based freelance photographer, ultra runner, and running coach for Chaski Endurance. He was exposed to the sport via a photo assignment, and has been running and shooting ever since, including wins at Keys100 and the Atacama Crossing. Other finishes include Western States and the Badwater 135. “The Keys100” IG - @run_n_shoot --- Send in a voice message: https://podcasters.spotify.com/pod/show/ray-zaragoza/message
We managed to get some time with Celebrity Influencers Keyan Zandy and Joe Donarumo, Authors of The Lean Builder. Felipe and I get to unearth several truths behind them writing this book. As usual, you best have your notepads ready to capture the secrets to unlocking a new level of performance with the Lean efforts on your Jobsite. The tips they dole out can be applied on any construction project with any team, and its best if you "start small". After you finish taking in all the goodness, share it with a colleague and leave us a comment.Connect with Joe & Keyan at: https://theleanbuilder.com/Connect with Felipe at: https://www.theebfcshow.com/Connect with us at: https://www.learningsandmissteps.com/
Change comes when we celebrate our differences. Zandy Wong is an advocate working to shatter inequities faced by people with disabilities. For more information about Zandy or to get connected with her, visit her Instagram at @zandy_wong.
Los Angeles-based writer actor and producer Zandy Hartig joins the pod for a conversation about Paul Thomas Anderson's 2017 historical romance Phantom Thread. Anderson's first film shot entirely outside of the United States, Phantom Thread is a hybrid of his detailed historical recreations like There Will Be Blood and The Master fused with Punch-Drunk Love's absurdist romantic sensibility. The film was said to be the final screen performance of the great Daniel Day-Lewis but it is also a generous showcase for the relatively unknown Luxembourgian actress Vicky Krieps. Zandy and I also talk about the film's extraordinary visual design and tone, what it has to say about adapting with the times, the challenges of living with a creative person and the role of the muse, and how Phantom Thread might be a secret comedy! Also Zandy talks about her ongoing collaboration with Oklahoma's prolific DIY filmmakers Mickey Reese and Jacob Ryan Snovel. Consider supporting the podcast directly by becoming a Junk Filter Patron and receive access to additional premium episodes every month: sign up at Patreon.com/junkfilter Follow Zandy Hartig on Twitter and check out zandyhartig.com Trailer for Phantom Thread (Anderson, 2017) Mickey Reese directs funny Instagram commercials for George's Liquors in Oklahoma City, and Zandy's in the latest one!
Zandy Mowry is one wise woman. She's one of the members of The New Respects, touring the country with her family band. When she's not on the road, you can find her in Nashville where she's building community and talking about how to be healthy in a world of hype. Goodness, we needed this conversation.
T2E08: Zandy se goza tanto el sexo que incluso cuando le toco una verga diminuta no lo pensó dos veces y se la comió y lo peor fue que le quedo gustando. Zandy nos cuenta que ha llegado a una madurez sexual donde lo que le importa es culiar y no la estría de aqui o el lunar de allá. Sigueme en INSTAGRAM --- Support this podcast: https://anchor.fm/orgasmosanonimos/support
Thank you for listening today (bare with the audio will be edited) this has been an exciting podcast year and this episode contributes to the success. Todays Episode is a conversation with Brother Zandy talking about Zero-D, Shifting, the application of.. https://www.facebook.com/100004314824349/videos/347374496795828/ The Zero- D (dimensions) is a common word in the energy modality world, fitness, self-help, massage, etc... There are many variations of this Term and we Believe They all contribute to the word and none more better than the other when defining. https://youtu.be/GzbRIRO577o Joe Vitale Zero Point https://youtu.be/Ra7KUsJ1J9w See Gregg Braden's Perspective On Zero Point https://youtu.be/YN2oALaRfL4 Center of Gravity idea Physics https://youtu.be/LYdYrZ4_3WE From Postural lens https://youtu.be/cNcunKRa_-M From a Balance and Stability Point of view https://youtu.be/1B0E1L2qfG4 Moving from your center What is Zero-D? It is in our best understanding, taking into considerations zero point, choice point, then you may understand that to start anything you need to come from something. A very important piece of movement is understand your plum line or center line of gravity. This is all zero D. Dancing and qigong is similar if you move from your center your zero point all will be manageable. What is shifting? You might of herd of Cognitive shifting and shifting is in part similar but also more wholistic as it includes all aspects of self. Shifting is similar to when you here the phrase "Raise Your Vibration" in that to shift you must deliberately do so. https://youtu.be/1EHI2hF9Iak Change how you think https://youtu.be/cHHEhevWZYE Flexibility Cognitive The Application of Zero- D "off the Mat" is when you can consciously shift back into a neutral cognitive flexible state of being. There no need to be drained by those energy vampires' if you can able shifting and finding your true center (zero-D) https://youtu.be/hLFIiHOoZT0 Dr. Northrup https://youtu.be/-GyPWcZXcN0 Energy Vampires Sharing is caring I mentioned a Product I really enjoy for over all health called I am Joy CB2, This is a powerful alchemy blend of 24K gold ormus (very cool stuff), Carbon- 60 What is C60? Read the Latest Research on Carbon 60 (sesres.com). Last but not lease Rose and Lavender Essence. Fin This Product and More on Amazon Type in I am Joy CB2 Tell your friends and family to tune in ....Coming soon is The Book Titled Zero Dimensions (Zero-D) Look for it soon (available through Amazon/Kindle) Subscribe to my Channels www.facebook.com/CoachBrianHarrington/ www.instagram.com/breathebrianharrington/ https://www.youtube.com/user/livinghealthdynamic1 --- Send in a voice message: https://anchor.fm/brian-harrington/message Support this podcast: https://anchor.fm/brian-harrington/support
The Get Hired! podcast was designed to get you real jobs in the real world. That’s why it’s important for us to talk about real issues. A tweet about a fresh graduate declining a 37k starting salary went viral recently. My business partner, Zandy, and I share our honest thoughts in this episode.
Welcome back! Today's episode is a different one, where I take a more laid back approach as Zandy talks to us about her disability advocacy work, her love for tennis, and the opportunities she's encountered at Johns Hopkins University. In this episode, you'll learn about JHU and if it's the right fit for you, as well as ways that YOU can promote inclusivity within the disabled community, and how Zandy has used her voice and her story to do just that. To learn more about Zandy, JHU, and ways in which you can help the disabled community, head over to the google doc here that will connect you with the resources and opportunities mentioned. Happy Listening! *Closed captioning is available.* Connect With Me! Instagram: @pouralittlebrain LinkedIn: Search 'Natalia Orso' Email: pouralittlebrain1@gmail.com --- Support this podcast: https://podcasters.spotify.com/pod/show/natalia-orso/support
Liebe Fangemeinde, wir heißen euch hiermit wieder herzlich willkommen! In dieser Episode haben wir mal wieder einige Themen für euch parat. Unser Hauptthema für die News-Sektion ist die Übernahme des Entwicklerstudios Next Level Games Inc. durch Nintendo. Wir unterhalten uns darüber, welche Studio unter Umständen noch auf Nintendos Einkaufszettel stehen könnten. Zusätzlich brodelt es weiterhin in der Gerüchteküche. Das Thema rund um die Nintendo Switch Pro wird einfach nicht langweilig! Nach einer hitzigen Diskussion kommen wir alle in der Kakaopause etwas runter. David nimmt uns mit seinem Classic "Quer durch das Weltall" auf einen Trip durch die Galaxie mit. Danach diskutieren wir in "What's loose?" über verschiedene Games, die wir gezockt haben. Unter anderem geht es um Super Mario 64, Among Us und Hyrule Warriors: Zeit der Verheerung. Im Anschluss hat David ini The Legend of Zandy noch ein paar Legenden für uns vorbereitet. Könnt ihr Wahrheit und Fiktion voneinander unterscheiden? Statt dem Debattierclub haben wir heute ein kleines Special vorbereitet. Die Tanooki Bros. haben Fanpost bekommen. Die Einsendung packen wir zum Zeitpunkt der Folge live aus und lassen uns überraschen, was wir so für Stuff erhalten haben. Danke auch nochmal an dieser Stelle an den Zusender ;) SHOUTOUT! In diesem Sinne viel Spaß mit Episode 13 und bis zum nächsten Mal! Eure Tanooki Bros. Time Stamps: Intro und Begrüßung (0:00:00) Big News (0:03:40) News Blitzrunde (0:26:00) Kakaopause (0:31:30) "What's loose?": Super Mario 64 (0:35:10) Hyrule Warriors: Zeit der Verheerung (0:40:25) Among Us (0:47:03) The Legend of Zandy (0:54:50) Outboxing der Fanpost (1:04:19) Abschied und Outro (1:20:40) Intro: SVS X - Tanooki Bros. Intro Kakaopause: Chronos 2.1 - Quer durch das Weltall Outro: Xenoblade Chronicles - Mechonis Field (OST) Folgt uns auf Instagram: https://www.instagram.com/tanookibros Oder schickt uns nette E-Mails auf talesoftanookibros@gmail.com
Thank you for tuning into another episode today we a specials guest and long time mentor Brother Zandy. We are going to dive deep into relationships, beauty walk, sweat lodges, "dusting off", and more on this journey of Real Yoga Talk Interview. This exceeds excitement because this new season is packed with guests from all walks of life that specialize in yoga, fitness, alternative healing, and human expansion, there will be something for every body. Plug in and tune in for your human expansion ride. This new season is titled Tales from Inner Space, if you or someone you know would be a great guest on this podcast please reach out to me at CoachBrian1088@gmail.com, I can't wait for all your comments, suggestions, and constructive criticism. Sharing is caring, pass this episode on! In Loving memory of JR "Packhorse" --- Send in a voice message: https://anchor.fm/brian-harrington/message Support this podcast: https://anchor.fm/brian-harrington/support
Diese Woche ist mein Gast die SuperZandy! Wir hatten es vor zwei Wochen ja schonmal versucht, da hat es aus gesundheitlichem Gewese nicht geklappt. Dafür isses jetzt diese Woche umso schöner, sie endlich hier zu haben. Wir sprechen über ihre Biene Maja Verbundenheit, ihre Zeit als Frank n Furter, wie sie mit dem Auflegen angefangen hat und somit wahrscheinlich Deutschlands erste Drag DJane wurde, wie sie Parties veranstaltet hat, die selbst von Vivienne Westwood und Thierry Mugler für großartig befunden wurden und wie sie heute das Leben so meistert, obwohl das Schicksal ihr immer mal wieder ein Bein gestellt hat. Es ist eins der "realsten" Gespräche geworden, das ich hier on air je geführt habe und ich bin super froh, dass sie die Zeit gefunden hat.
Zandy's five personal tips and advice when it comes to getting your life organized, back on track.... or in other words getting your shit together.
Wairarapa Romney Improvement Group recently celebrated its 50th anniversary. Chair Zandy Wallace shares where the future lies for the pioneering ram breeders. To watch to the full-length interviews and to contact the show visit www.sarahperriam.com
Have you ever woken up and thought, hey, ya know something, I’ve never run an ultramarathon, how about I go and sign up for a multi-stage ultra in the Australian Outback? What could go wrong? If you want to know what not to do, our next guest is your man...he’s also won the 6-stage Atacama Crossing in Chile, so he also kinda knows what to do as well. I gotta say, I haven’t laughed this much during a taping. Maybe it was the cold and flu medicine, or maybe there were some gems in there...you’ll have to decide. Follow Zandy's adventures on Instagram. We call this one #digdeep #justsignup... Let’s get to it. ➡ Follow us on IG: instagram.com/storiesfromtherun
Kim Zandy is a RI Radio Hall of Fame broadcaster. Co-Host of the wildly popular Giovanni and Kim Show on 92 ProFM. She's also a very interesting and VERY smart human being. We talk a little about her radio story but also about her adventure with foster parenting and adoption. You will enjoy conversation, I PROMISE!!Don't for get to subscribe wherever you get your podcasts to get these episodes delivered to you directly!!!
Mariano Conti, the head of smart contracts for MakerDAO and creator of SelloutDAO, and Peter Pan, the summoner for Metacartel DAO, discuss all things DAOs, including how Peter started Metacartel DAO after being rejected from MolochDAO, and why Mariano initially voted against Peter joining. (Peter eventually joined.) They also discuss how they came to form YangDAO, why Mariano almost rage quit MolochDAO after the YangDAO formed, and how other MolochDAO members felt about SelloutDAO, which Mariano describes as an experiment in "on-chain corruption." We discuss how DAOs are actually heavily built on trust and why they require a lot of social coordination off-chain. They also discuss funding for LAOs, which have a legal entity such as an LLC affiliated with them, why Metacartel is launching a LAO, and which types of projects should be funded by DAOs vs traditional corporate structures. We also cover governance issues at MakerDAO, why it has a CEO, and what role leadership in general plays in a DAO. Thank you to our sponsors! Crypto.com: https://crypto.com/ Kraken: https://www.kraken.com CipherTrace: http://ciphertrace.com/unchained Episode links: Mariano Conti: https://twitter.com/nanexcool Peter Pan: https://twitter.com/pet3rpan_ MakerDAO: https://makerdao.com/en/ https://chat.makerdao.com Metacartel DAO: https://www.metacartel.org/ https://twitter.com/meta_cartel SelloutDAO: https://selloutdao.com/ Unchained interview with Ameen Soleimani of MolochDAO: https://unchainedpodcast.com/molochdao-could-this-decentralized-autonomous-organization-help-ethereum-scale-faster/ Unchained interview with Santiago Siri: https://unchainedpodcast.com/how-blockchains-can-help-create-little-democracies-everywhere/ DAO Revival: https://www.coindesk.com/in-berlin-a-dao-renaissance-begins https://www.bloomberg.com/news/features/2019-10-05/crypto-rebels-trip-over-each-other-en-route-to-financial-utopia Andy Milenius’s account of MakerDAO’s change from a decentralized to a centralized project: https://www.scribd.com/document/407743542/Zandy-s-Story CoinDesk story on the rift: https://www.coindesk.com/darkest-days-yet-purple-pill-tell-all-details-years-long-rift-at-heart-of-makerdao-stablecoin-project Two most recent MakerDAO votes: https://vote.makerdao.com/executive-proposal/keep-the-stability-fee-set-to-a-total-of-105-per-year https://vote.makerdao.com/executive-proposal/lower-the-stability-fee-by-2-to-a-total-of-85-per-year https://vote.makerdao.com/polling-proposal/qmpem83sxjjwe1jvn2csdtetn4r3j95ejuzpbmtxef4lu5 Unchained interviews with Rune Christensen of MakerDAO: Part 1: https://unchainedpodcast.com/rune-christensen-of-makerdao-part-1-how-to-keep-a-crypto-collateralized-stablecoin-afloat/ Part 2: https://unchainedpodcast.com/rune-christensen-of-makerdao-part-2-how-dai-stayed-at-1-while-eth-crashed-from-1400-to-85/ MakerDAO vulnerabilities: ETH could have been stolen: https://hackerone.com/reports/684092 https://thenextweb.com/hardfork/2019/10/03/makerdao-security-vulnerability-ethereum-dai-stablecoin-collapse-theft-cryptocurrency/ The LAO: https://medium.com/openlawofficial/the-lao-a-for-profit-limited-liability-autonomous-organization-9eae89c9669c Critique of the LAO: https://prestonbyrne.com/2019/09/03/the-lao-demystified/ MakerDAO launching multi-collateral Dai: https://www.coindesk.com/makerdaos-multi-collateral-dai-token-is-launching-nov-18 https://blog.makerdao.com/breaking-launch-date-of-multi-collateral-dai-announced-at-devcon-5/ Are DAO’s legal? https://www.coindesk.com/new-interest-in-daos-prompts-old-question-are-they-legal Unconfirmed interview with Uniswap: https://unchainedpodcast.com/how-uniswap-quickly-became-one-of-the-most-popular-dexes/ Unconfirmed episode with Ryan Zurrer about resurrecting the DAO: https://unchainedpodcast.com/why-ryan-zurrer-would-like-to-see-a-new-dao/ Unchained interview with Aragon: https://unchainedpodcast.com/how-aragon-hopes-to-improve-on-democracy/
Mariano Conti, the head of smart contracts for MakerDAO and creator of SelloutDAO, and Peter Pan, the summoner for Metacartel DAO, discuss all things DAOs, including how Peter started Metacartel DAO after being rejected from MolochDAO, and why Mariano initially voted against Peter joining. (Peter eventually joined.) They also discuss how they came to form YangDAO, why Mariano almost rage quit MolochDAO after the YangDAO formed, and how other MolochDAO members felt about SelloutDAO, which Mariano describes as an experiment in "on-chain corruption." We discuss how DAOs are actually heavily built on trust and why they require a lot of social coordination off-chain. They also discuss funding for LAOs, which have a legal entity such as an LLC affiliated with them, why Metacartel is launching a LAO, and which types of projects should be funded by DAOs vs traditional corporate structures. We also cover governance issues at MakerDAO, why it has a CEO, and what role leadership in general plays in a DAO. Thank you to our sponsors! Crypto.com: https://crypto.com/ Kraken: https://www.kraken.com CipherTrace: http://ciphertrace.com/unchained Episode links: Mariano Conti: https://twitter.com/nanexcool Peter Pan: https://twitter.com/pet3rpan_ MakerDAO: https://makerdao.com/en/ https://chat.makerdao.com Metacartel DAO: https://www.metacartel.org/ https://twitter.com/meta_cartel SelloutDAO: https://selloutdao.com/ Unchained interview with Ameen Soleimani of MolochDAO: https://unchainedpodcast.com/molochdao-could-this-decentralized-autonomous-organization-help-ethereum-scale-faster/ Unchained interview with Santiago Siri: https://unchainedpodcast.com/how-blockchains-can-help-create-little-democracies-everywhere/ DAO Revival: https://www.coindesk.com/in-berlin-a-dao-renaissance-begins https://www.bloomberg.com/news/features/2019-10-05/crypto-rebels-trip-over-each-other-en-route-to-financial-utopia Andy Milenius's account of MakerDAO's change from a decentralized to a centralized project: https://www.scribd.com/document/407743542/Zandy-s-Story CoinDesk story on the rift: https://www.coindesk.com/darkest-days-yet-purple-pill-tell-all-details-years-long-rift-at-heart-of-makerdao-stablecoin-project Two most recent MakerDAO votes: https://vote.makerdao.com/executive-proposal/keep-the-stability-fee-set-to-a-total-of-105-per-year https://vote.makerdao.com/executive-proposal/lower-the-stability-fee-by-2-to-a-total-of-85-per-year https://vote.makerdao.com/polling-proposal/qmpem83sxjjwe1jvn2csdtetn4r3j95ejuzpbmtxef4lu5 Unchained interviews with Rune Christensen of MakerDAO: Part 1: https://unchainedpodcast.com/rune-christensen-of-makerdao-part-1-how-to-keep-a-crypto-collateralized-stablecoin-afloat/ Part 2: https://unchainedpodcast.com/rune-christensen-of-makerdao-part-2-how-dai-stayed-at-1-while-eth-crashed-from-1400-to-85/ MakerDAO vulnerabilities: ETH could have been stolen: https://hackerone.com/reports/684092 https://thenextweb.com/hardfork/2019/10/03/makerdao-security-vulnerability-ethereum-dai-stablecoin-collapse-theft-cryptocurrency/ The LAO: https://medium.com/openlawofficial/the-lao-a-for-profit-limited-liability-autonomous-organization-9eae89c9669c Critique of the LAO: https://prestonbyrne.com/2019/09/03/the-lao-demystified/ MakerDAO launching multi-collateral Dai: https://www.coindesk.com/makerdaos-multi-collateral-dai-token-is-launching-nov-18 https://blog.makerdao.com/breaking-launch-date-of-multi-collateral-dai-announced-at-devcon-5/ Are DAO's legal? https://www.coindesk.com/new-interest-in-daos-prompts-old-question-are-they-legal Unconfirmed interview with Uniswap: https://unchainedpodcast.com/how-uniswap-quickly-became-one-of-the-most-popular-dexes/ Unconfirmed episode with Ryan Zurrer about resurrecting the DAO: https://unchainedpodcast.com/why-ryan-zurrer-would-like-to-see-a-new-dao/ Unchained interview with Aragon: https://unchainedpodcast.com/how-aragon-hopes-to-improve-on-democracy/
This week I speak to Zandy Fell about her journey from the boardrooms of Toyota as their Diversity and Equal opportunity manager Employee relations Manager and National recruitment Manager To running her own business, The Zalt Group. Zandy says there is nothing soft and fluffy about workplace relations and I can really see that now, enjoy as we cover: - HR - Values and Idealism - HR and ER - not a soft skill - It really is the silly things - emotions run high - The female assumptions in business - Feelings - Nothing more than feelings - Conflict needs a PR remodel - a good workplace is the ability to deal with difference and can get an organisation to a better place - “Don’t take it personally” Be rational - change your thinking! - Conflict is a leakage point - it is a loss of hours, mental space and - and most companies don’t measure it - Who has the power - the manager or the subordinate - HR is a strategic advantage - We’ve all got the skills for conflict resolution
The Consistent Genius Podcast is about anything and everything! Hosted by Billy Seach.Find out more at https://consistent-genius.pinecast.co
The Consistent Genius Podcast is about anything and everything! Hosted by Billy Seach.Find out more at https://consistent-genius.pinecast.co
Wir heißen hiermit alle herzlich willkommen zu unserer ersten Sendung der Tanooki Bros! Während wir diesmal nur zu zweit sind, versuchen wir mit heißen News aus der Nintendo-Szene durchzustarten. Egal ob Nindies, Triple-A oder Gerüchte über neue Switch-Modelle - wir liefern euch alles! Im „What's Loose?!“-Segment versucht Jorgo verzweifelt ein Spiel zu finden, über das er berichten wird und David erzählt über seine bitteren Erfahrungen als Rare-Fan.Nach einer genüsslichen Runde Kakao, geht es dann über zu einem „unfassbaren“ Ratespiel, bei dem die Grenzen zwischen Wahrheit und Lüge verschwimmen. Werdet ihr richtig liegen? Man weiß es nicht... Im Debattierclub geht es um das Erbe von Iwata und den Grundstein, den er für Nintendos Zukunft gelegt hat. Außerdem klären wir die Frage, was Cuphead damit zu tun hat. Zum Abschluss gibt es einen schönen Track aus unseren Spielearchiven, diesmal aus dem GameBoy-Spiel Obelix von Infogrames. Komponiert wurde das gute Teil von Alberto Jose Gonzalez. Viel Spaß mit dieser Folge und bis zum nächsten Mal! Eure Tanooki Bros. Intro: SVS X - Tanooki Bros. Intro Kakaopausetrack: Chronos 2.1 & Oeb - The Legend of Zandy (prod. by SVS X) Outro: Obelix OST - Holiday (prod. by Alberto Jose Gonzalez)
Happy Belated International Women's Day! Sorry we forgot to post, we were busy celebrating by... wait, how do you celebrate it again? Maybe the tabloids can help us figure it out. Plus, Emily Ratajkowski Nails the Mid-Winter Ab Reveal (or whatever that means) and Farrah Abraham (yes, that one) is Penthouse's new book critic. Jaime King clutches a parenting book while in Beverly Hills... one year after she was attacked by a crazed man in the same city (Daily Mail's words, not ours) and Bethenny has leaky gut syndrome! We'll ask WebMD about that in a sec! As always, call in at 619.WHO.THEM with your questions and comments, and don't forget to support us on Patreon for a jam-packed weekly newsletter and fortnightly bonus episodes. Plus, this week we'll be doing a daily show on SiriusXM radio, so head to siriusxm.com/whoweekly and for a free three month trial.
Anesthesia and Critical Care Reviews and Commentary (ACCRAC) Podcast
In this 111th episode I welcome Dr. Zandy Hillel to the show. Dr. Hillel is an otolaryngologist here at Johns Hopkins and we discuss tracheostomies, Cricothyrotomies, laryngeal surgery and difficult airways. References: Crichothyrotomies: https://www.ncbi.nlm.nih.gov/pubmed/30054081 https://www.ncbi.nlm.nih.gov/pubmed/30726035 Difficult Airway Response Teams: https://www.ncbi.nlm.nih.gov/pubmed/26086513
This week's show features an amazing photographer and awesome ultra runner Zandy Mangold! Zandy started ultrarunning after being hired as the photographer for the Racing the Planet series. Since then he has been all around the world and has participated in a wide variety of races- everything from week long stage races in Chile to the Badwater 135 to the Georgia Death Race and so much more!! In this episode Zandy explains the journey of turning his passion for photography into his career. He also gives us a rundown of the 4 desert races, talks about the conundrum of watching people suffer through an ultra marathon only to think to yourself "I think I should do this!" and describes the extreme heat he faced at Badwater this year. Hope you guys enjoy the show! I really loved chatting with Zandy. I always think it's super inspiring when someone is living their life guided by their passions! Be sure to check out all of his photos by following run_n_shoot on instagram https://www.instagram.com/run_n_shoot/?hl=ens. His work is incredible! MORE FROM ZANDY MANGOLD: Instagram: https://www.instagram.com/run_n_shoot/?hl=en Twitter: https://twitter.com/zandymangold?lang=en Website: https://zandymangoldnyc.com National Geographic Article: https://www.nationalgeographic.com/adventure/features/ultramarathon-runner-science-obsession-pain-culture/ MORE LIKE A BIGFOOT: Subscribe and Review on iTunes: https://itunes.apple.com/us/podcast/like-a-bigfoot/id1160773293?mt=2 Soundcloud Archives: https://soundcloud.com/chris-ward-126531464 Facebook Group: https://www.facebook.com/likeabigfoot/ Instagram: https://www.instagram.com/likeabigfoot/
In her first story collection since Love in Infant Monkeys, which became a Pulitzer Prize finalist, Lydia Millet explores what it means to be home. Nina, a lonely real-estate broker estranged from her only relative, is at the center of a web of stories connecting fractured communities and families. She moves through the houses of L.A.’s wealthy elite and finds men and women both crass and tender, vicious and desperate. With wit and intellect, Millet offers profound insight into human behavior from the ordinary to the bizarre: strong-minded girls are beset by the helpless, myopic executives are tormented by their employees, and beastly men do beastly things. Millet is in conversation with Zandy Hartig, an actress known for her roles in Children's Hospital, Wanderlust, Role Models, and The Ten.
ONLY THREE MORE WEEKS UNTIL THE ROYAL WEDDING! You can watch it LIVE at 7AM on SATURDAY, MAY 19 with YOUR FAVORITE PODCAST HOSTS (I'm talking about us btw) as part of this year's Vulture Fest. For ticket info, just check our feeds because you know we're going to promote the hell out of it. Anyway, this week we discuss Meghan Markle's FIRST wedding of 2018: the one on Suits! Yep, she was written out of the show with a wedding. (We watched the episode, but still have no idea what Suits is about. I think something about lead? Whatever.) Speaking of weddings: ZANDY! LEA! THE GHOST OF COREY! Speaking of weddings again: WESTON CAGE! SOMEONE NAMED HILA ARONIAN! But enough about them, because our big story of the week is more important. Did you know Miranda Lambert's trail of exes is helping to create one of the most captivating current celebrity gossip stories? There are weird names for days, messy social media behavior, and cold calls to the out-of-the-loop FATHERS of certain parties. Who knew?
Conflict in the workplace is inevitable. No matter how perfect a workplace may look from the outside, conflict is bound to happen one way or another. In this episode you’ll learn how to handle the inevitable complexities of workplace relationships and appreciate the importance of engaging in difficult conversations. Tony and Zandy Fell of the Zalt Group specialise in helping businesses resolve internal conflicts among staff. And when things are beyond repair, they assist in managing the fallout to minimise the long term damage to the business Today they share with us some real-life stories of conflict and help us better understand the blurred lines between our business and personal lives. We also hear their take on high profile cases in the media around workplace relationships and alleged inappropriate behaviors. “You need to be flexible in your approach, your approach is not the only way to do things.” - Tony Fell “Conflicts are more positive than people think.” - Zandy Fell “Effective workplace relationships are a strategic advantage. If you’ve got good relationships in the workplace, you will be able to achieve what you need to.” - Zandy Fell Today on the Finance Hour Podcast: How big an issue conflict is in the workplace and its negative impact on the business. How conflict affects business decisions. Why conflicts usually take longer to resolve in large businesses. How Zandy and Tony help businesses determine what is acceptable behavior in the workplace. How the objectives of different business partners may change over time and what to do about it. How to educate employees on the impact of their social media activity on the workplace. Tony and Zandy’s top three tips for managing conflicts at work. And don’t forget to listen all the way to the end for our “Propellerhead of the week” which is about why investors should be looking more closely at principal and interest loans. Mentioned Resources: Zalt Group Tony Fell LinkedIn profile Zandy Fell LinkedIn profile Thanks for tuning in! Thanks for joining us on today’s episode of The Finance Hour podcast! If you enjoyed today’s episode, please head over to iTunes and leave us a rate and review to help us reach even more listeners. Don’t forget to check out our website, visit us on Facebook, or hang out with us on Twitter to stay up-to-date on what’s in store for you! See omnystudio.com/listener for privacy information.
Teddy Savas, Deputy Director of the RI Department for Children, Youth and Families and Kim Zandy of 92 PRO-FM, a foster and adoptive parent discuss Rhode Island's efforts to attract more foster families. More than 250 youngsters in the state are in need of placement with a foster family.With grants from the Rhode Island Foundation and the Annie E. Casey Foundation, the state raises more than $1.3 million to increase the number of foster homes available in the state. http://www.dcyf.ri.gov www.92profm.com
Actor Zandy Hartig talks about what it’s like to be directed by the likes of Soderbergh, and the good and bad of being directed by a genius like Kubrick. Download the file here: Shining Episode 7 Vinessa Shaw with Tom Cruise in Kubrick’s Eyes Wide Shut. (If anyone has the clip of […]
Autism Village founder Topher Wurts says that with a special needs diagnosis, a parent's “imaginary future child” dies all at once instead of by a thousand cuts over twenty years. In today's show, Topher shares his family's caregiving journey with son Kirby, who was diagnosed with autism at eighteen months old. From altered careers and tricky social situations, to the all-autistic Boy Scout troop Kirby thrives in and balancing time with neurotypical son, Zandy, celebrating each day is what this family is all about. Topher also tells us how he used his background in tech media to develop Autism Village, a free, Yelp-like mobile app for autism families, and how his non-profit Autism Friendly is training businesses to better serve clients on the autism spectrum.To purchase a transcript of this episode please visit this page: TranscriptsAutism Village (free app)Training for businesses:Additional Resources: “Born on a Blue Day” by Daniel Tammet“Ten Things Every Child With Autism Wishes You Knew” by Ellen NotbohmBooks by Temple GrandinLearn about jazz pianist Matt Savage
It's a JV Club re-release! It's tough to beat New York City in the 1980's, as this week's guest Zandy Hartig (Childrens Hospital) proves with memories of museums, clubs, and a very special classroom. Plus: Sting!
My friend Darius Fitzgerald joins the show this week & he plays in a band called The New Respects. You might remember his sister Zandy being in the show back in August. They've recently just done 6 weeks on the road with Crowder & Tedashi so we talk all about bus life, playing 20 or so shows in a row, music inspiration & much much more. These gals & guy in The New Respects are taking over the world very fast. Im excited to see where all it goes!
My friend Zandy from The New Respects joins us on the podcast today. Their band is taking off like a rocket right now so I'm more than stoked to have gotten an hour of her time while she's home. We talk all about how quickly things are moving for the band right now & much much more. Check it out, fam! // @zandyfitz on socials
Zandy Hartig (@zandywithaz) joins the ladies to discuss Irish goodbyes, medevil times, Game of Thrones, Father's Day, glamping, Joshua Tree, getting engaged and more!
It's tough to beat New York City in the 1980's, as this week's guest Zandy Hartig (Childrens Hospital) proves with memories of museums, clubs, and a very special classroom. Plus: Sting!